matrivax / HOME |

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Allow: / # Optimization for Google Ads Bot User-agent: AdsBot-Google-Mobile User-agent: AdsBot-Google Disallow: /_api/* Disallow: /_partials* Disallow: /pro-gallery-webapp/v1/galleries/* # Block PetalBot User-agent: PetalBot Disallow: / Sitemap: https://www.matrivax.com/sitemap.xml # Auto generated, go to SEO Tools > Robots.txt Editor to change

Meta Tags

Title	HOME \|
Description	A next-generation, broad-coverage pneumococcal disease top of page HOME About Us Pipeline Pneumococcal Vaccine Candidate MVX01 C. difficile Vaccine Candidate MVX02 News / Publications Contact Us Streptococcus
Keywords	N/A

Server Information

WebSite	matrivax.com
Host IP	23.236.62.147
Location	United States

Related Websites

                        Site
                        Rank
                    

More to Explore

matrivax.com Valuation

US$2,468,346

Last updated: 2023-05-17 12:47:49

matrivax.com has Semrush global rank of 4,288,015. matrivax.com has an estimated worth of US$ 2,468,346, based on its estimated Ads revenue. matrivax.com receives approximately 284,810 unique visitors each day. Its web server is located in United States, with IP address 23.236.62.147. According to SiteAdvisor, matrivax.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$2,468,346
Daily Ads Revenue	US$2,279
Monthly Ads Revenue	US$68,355
Yearly Ads Revenue	US$820,251
Daily Unique Visitors	18,988
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
matrivax.com.	A	3599	IP: 23.236.62.147
matrivax.com.	NS	86400	NS Record: ns3.p30.dynect.net.
matrivax.com.	NS	86400	NS Record: ns4.p30.dynect.net.
matrivax.com.	NS	86400	NS Record: ns1.p30.dynect.net.
matrivax.com.	NS	86400	NS Record: ns2.p30.dynect.net.
matrivax.com.	MX	3600	MX Record: 10 us-smtp-inbound-2.mimecast.com.
matrivax.com.	MX	3600	MX Record: 10 us-smtp-inbound-1.mimecast.com.
matrivax.com.	TXT	3600	TXT Record: v=spf1 include:spf.protection.outlook.com include:us._netblocks.mimecast.com ~all
matrivax.com.	TXT	3600	TXT Record: 0ed1fe018adb3b879c80af4947aab5bafbd6bdf96b
matrivax.com.	TXT	3600	TXT Record: MS=ms79402319

HtmlToTextCheckTime:2023-05-17 12:47:49

top of page HOME About Us Pipeline Pneumococcal Vaccine Candidate MVX01 C. difficile Vaccine Candidate MVX02 News / Publications Contact Us Streptococcus pneumoniae A next-generation, broad-coverage pneumococcal disease vaccine Despite a number of commercially available vaccines, Streptococcus pneumoniae infections are still responsible for more than 1,000,000 deaths worldwide per year! We are developing a next-generation, recombinant protein vaccine to profoundly reduce the devastating global impact of pneumococcal disease. Learn More Clostridiodes difficile A novel C. difficile vaccine that targets the bacteria and the toxins Clostridiodes difficile , classified by the US Centers for Disease Control and Prevention (CDC) as an urgent public health threat, is estimated to cause half a million infections per annum in the US alone. We are developing a novel, triple antigen C. difficile vaccine that targets the bacteria and the toxins, reducing bacterial colonization and preventing

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Sat, 26 Mar 2022 09:14:09 GMT
Content-Length: 0
Connection: keep-alive
location: https://www.matrivax.com/
strict-transport-security: max-age=3600
Age: 67556
Server-Timing: cache;desc=hit, varnish;desc=hit, dc;desc=42
X-Seen-By: jeslxIFvDH4ulYwNNi+3Muwfbs+7qUVAqsIx00yI78k=,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVivd4o9HMoDTVPhK7/s60Jl,m0j2EEknGIVUW/liY8BLLvRKfhx2uNN4hv3eFGgKFZEa0sM5c8dDUFHeNaFq0qDu,2d58ifebGbosy5xc+FRalqgK37rCJbCfjKTwD27n2ZRbRqnJmxtYlFBc56GS2tlY9Gs3T6AXxFfDVFaSaY5CjQ==,2UNV7KOq4oGjA5+PKsX47Jd4VuvfJ1SBRYQbzdkhcG0fbJaKSXYQ/lskq2jK6SGP
Cache-Control: no-cache
X-Wix-Request-Id: 1648286049.16225826201231213388
X-Content-Type-Options: nosniff

HTTP/2 200 
date: Sat, 26 Mar 2022 09:14:09 GMT
content-type: text/html; charset=UTF-8
content-length: 395116
link: ; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,
etag: W/"b9f3b8a1d1e404929203c9cd06d256bc"
content-language: en
strict-transport-security: max-age=3600
age: 50207
set-cookie: ssr-caching=cache#desc=hit#varnish=hit#dc#desc=euw3; Max-Age=20; Expires=Fri, 25 Mar 2022 19:17:41 GMT
server-timing: cache;desc=hit, varnish;desc=hit, dc;desc=euw3
x-seen-by: sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVg6HfnW4YM4HE462N/9JQwG,qquldgcFrj2n046g4RNSVFHX+9pl0hogZJEnMG0iIcI=,2d58ifebGbosy5xc+FRalh6PNwQIW9gcrEsrFIfE5qNcS3EfSatG5JUrIsP81vvQjoe2GMQJ/MdiMK4Y/vI70/Ypsxd90qrRuIWZcXZ4dtI=,2UNV7KOq4oGjA5+PKsX47CK4wJ01aY3ZbqTi7BzxQjE=
cache-control: no-cache
vary: Accept-Encoding
accept-ranges: bytes
x-wix-request-id: 1648286049.41432699526413821
x-content-type-options: nosniff
server: Pepyaka/1.19.10

matrivax.com Whois Information

Domain Name: MATRIVAX.COM
Registry Domain ID: 1255483747_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.networksolutions.com
Registrar URL: http://networksolutions.com
Updated Date: 2021-10-07T20:48:58Z
Creation Date: 2007-10-04T19:02:07Z
Registry Expiry Date: 2026-10-04T19:02:07Z
Registrar: Network Solutions, LLC
Registrar IANA ID: 2
Registrar Abuse Contact Email: abuse@web.com
Registrar Abuse Contact Phone: +1.8003337680
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS1.P30.DYNECT.NET
Name Server: NS2.P30.DYNECT.NET
Name Server: NS3.P30.DYNECT.NET
Name Server: NS4.P30.DYNECT.NET
DNSSEC: unsigned
>>> Last update of whois database: 2022-03-26T10:34:04Z <<<

matrivax.com valuation and analysis